These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 20715519)
1. [Long-term efficacy and safety of pregabalin in patients with postherpetic neuralgia: results of a 52-week, open-label, flexible-dose study]. Ogawa S; Suzuki M; Arakawa A; Yoshiyama T; Suzuki M Masui; 2010 Aug; 59(8):961-70. PubMed ID: 20715519 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China. Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113 [TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin. Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study. Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy or postherpetic neuralgia: Open-label, non-comparative, flexible-dose study. Baron R; Brunnmüller U; Brasser M; May M; Binder A Eur J Pain; 2008 Oct; 12(7):850-8. PubMed ID: 18242109 [TBL] [Abstract][Full Text] [Related]
6. Long-term safety of gastroretentive gabapentin in postherpetic neuralgia patients. Jensen MP; Irving G; Rauck R; Wallace M; Sweeney M; Vanhove GF Clin J Pain; 2013 Sep; 29(9):770-4. PubMed ID: 23370075 [TBL] [Abstract][Full Text] [Related]
7. Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief. Stacey BR; Barrett JA; Whalen E; Phillips KF; Rowbotham MC J Pain; 2008 Nov; 9(11):1006-17. PubMed ID: 18640074 [TBL] [Abstract][Full Text] [Related]
8. Pregabalin for peripheral neuropathic pain: results of a multicenter, non-comparative, open-label study in Indian patients. LYRICA Study Group Int J Clin Pract; 2006 Sep; 60(9):1060-7. PubMed ID: 16939547 [TBL] [Abstract][Full Text] [Related]
9. Pregabalin and transcutaneous electrical nerve stimulation for postherpetic neuralgia treatment. Barbarisi M; Pace MC; Passavanti MB; Maisto M; Mazzariello L; Pota V; Aurilio C Clin J Pain; 2010 Sep; 26(7):567-72. PubMed ID: 20639738 [TBL] [Abstract][Full Text] [Related]
10. A prospective, open-label, multicentre study of pregabalin in the treatment of neuropathic pain in Latin America. Xochilcal-Morales M; Castro EM; Guajardo-Rosas J; Obregón TN; Acevedo JC; Chucan JM; Plancarte-Sanchez R; Davila G; Wajsbrot D; Guerrero M; Vinueza R Int J Clin Pract; 2010 Aug; 64(9):1301-9. PubMed ID: 20487048 [TBL] [Abstract][Full Text] [Related]
11. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study. Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723 [TBL] [Abstract][Full Text] [Related]
12. Once-daily gastroretentive gabapentin for postherpetic neuralgia: integrated efficacy, time to onset of pain relief and safety analyses of data from two phase 3, multicenter, randomized, double-blind, placebo-controlled studies. Rauck RL; Irving GA; Wallace MS; Vanhove GF; Sweeney M J Pain Symptom Manage; 2013 Aug; 46(2):219-28. PubMed ID: 23149085 [TBL] [Abstract][Full Text] [Related]
13. Pregabalin in the treatment of refractory neuropathic pain: results of a 15-month open-label trial. Stacey BR; Dworkin RH; Murphy K; Sharma U; Emir B; Griesing T Pain Med; 2008 Nov; 9(8):1202-8. PubMed ID: 18346060 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial. Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937 [TBL] [Abstract][Full Text] [Related]
15. Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial. Siddall PJ; Cousins MJ; Otte A; Griesing T; Chambers R; Murphy TK Neurology; 2006 Nov; 67(10):1792-800. PubMed ID: 17130411 [TBL] [Abstract][Full Text] [Related]
16. Gastroretentive gabapentin (G-GR) formulation reduces intensity of pain associated with postherpetic neuralgia (PHN). Sang CN; Sathyanarayana R; Sweeney M; Clin J Pain; 2013 Apr; 29(4):281-8. PubMed ID: 22801243 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy. Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M Curr Med Res Opin; 2009 Jul; 25(7):1677-87. PubMed ID: 19480610 [TBL] [Abstract][Full Text] [Related]
18. Replacement of gabapentin with pregabalin in postherpetic neuralgia therapy. Ifuku M; Iseki M; Hidaka I; Morita Y; Komatus S; Inada E Pain Med; 2011 Jul; 12(7):1112-6. PubMed ID: 21692969 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial. van Seventer R; Feister HA; Young JP; Stoker M; Versavel M; Rigaudy L Curr Med Res Opin; 2006 Feb; 22(2):375-84. PubMed ID: 16466610 [TBL] [Abstract][Full Text] [Related]
20. Pregabalin treatment for peripheral neuropathic pain: a review of safety data from randomized controlled trials conducted in Japan and in the west. Ogawa S; Satoh J; Arakawa A; Yoshiyama T; Suzuki M Drug Saf; 2012 Oct; 35(10):793-806. PubMed ID: 22967187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]